article thumbnail

Biopharma Update on the Novel Coronavirus: October 20

The Pharma Data

DB ( Becton, Dickinson and Company ) received a CE mark for its BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes for assessing immune function in COVID-19 patients. In a challenge trial, people are given a vaccine then intentionally dosed with the virus or bacteria that causes the disease. Please read more here. .

article thumbnail

Reflecting on ELRIG’s Drug Discovery 2022 

Drug Discovery World

There was a selection of the technologies we will present including cell-based assays, ion indicator dyes, inhibitors, pharmacokinetic assays, bioisimilars, assay development antibodies, conjugation particles and other reagents for your drug discovery and development pipeline. . Looking forward .

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can a plant-based discovery pave the way for new drug treatments?

Drug Discovery World

This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. The researchers took an enzyme called OaAEP1 from Oldenlandia affinis, a small purple flower that grows in the tropics, and modified it before transferring it into bacterial cells. It is therefore much simpler and cheaper.

Protein 59
article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. This is an exciting field of cancer research which involves harnessing the body’s own immune system to target cancerous cells.

article thumbnail

BioSpace Global Roundup: Ipsen Wins Fast Track Designation for Cancer Drug and More

The Pharma Data

Howard Mayer, Ipsen’s head of research and development, called the Fast Track designation for Onivyde “an extension of Ipsen’s focus and contribution” to the oncology landscape. aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. in Mainland China. in Mainland China.

Drugs 52
article thumbnail

Rising Demand for DNA and Gene Cloning  Service Providers

Roots Analysis

This has enabled several researchers to study genetic disorders more precisely and closely. Further, the labor and reagent cost incurred in cloning procedures is reduced with customized cloning. Along with this, the high quality DNA clones and gene clones are customized as per the need and requirement.

DNA 40
article thumbnail

CRISPR breakthroughs: New solutions for common diseases

Drug Discovery World

Years of development and fast-paced research have continued to unlock its potential, expanding how CRISPR can be used to treat, detect, and prevent common diseases such as cancer and Covid-19. Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g., Herpesviridae, Polyomaviridae, and Papillomaviridae), bacteria (e.g.,

DNA 98